Anrukinzumab (Anti-IL-13)
Anrukinzumab (Anti-IL-13) is a humanized monoclonal antibody targeting IL-13. It reduces lung inflammation and can be used in studies of ulcerative colitis (UC) as well as asthma. MW :150 KD.
| Trivial name | IMA-638 |
| Catalog Number | A2665 |
| CAS# | 910649-32-0 |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/anrukinzumab-anti-il-13-.html |